2018 Barriers of the CNS Gordon Research Conference and Gordon Research Seminar
2018 Barriers of the CNS Gordon Research Conference and Gordon Research Seminar
批准号:
9542556
负责人:
William Elmquist
金额:
$2.39万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-03-01 至 2019-02-28
关键词:
AddressAlzheimer&aposs DiseaseBioinformaticsBiomedical EngineeringBloodBlood - brain barrier anatomyBlood CirculationBrainBrain NeoplasmsCentral Nervous System DiseasesClinicalCollaborationsCommunitiesComplexComputer SimulationDevelopmentDiagnosisDiagnosticDiseaseDrug Delivery SystemsEnvironmentEpithelialFacultyFeedbackFosteringFundingGoalsGrowth and Development functionHealthHomeostasisImmune systemInternationalKnowledgeLeadMaintenanceMeasuresMentorsMentorshipMetastatic malignant neoplasm to brainMethodsMolecularNeuraxisNew HampshireParticipantPharmaceutical PreparationsPostdoctoral FellowPublic HealthRegulationRequest for ApplicationsRequest for ProposalsResearchResearch MethodologyResearch PersonnelRoleScienceScientistSenior ScientistStructureStudentsTechnologyTherapeuticcareercollegedata miningfluid flowgenetic signatureimprovedinnovationinsightinterestintravital microscopymathematical modelmeetingsmultidisciplinarynervous system disorderneurotoxicnew technologynovelnovel strategiespalliativepeerposterspreventsymposiumtranscriptometumor growth
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary / Abstract
This proposal requests support for partial funding of the 2018 “Barriers of the Central Nervous System
(CNS)” GRC and GRS that will be held at Colby Sawyer College, New Hampshire, on June 16-17, 2018
(GRS) and June 17-22, 2018 (GRC). The overall goal of this international conference is to improve
understanding of the highly complex cellular and molecular mechanisms regulating the function of the
endothelial (e.g. blood-brain barrier (BBB)) and epithelial (e.g. blood-CSF barrier (BCSFB)) brain barriers in
development, maintenance and disease. The 2018 meetings will achieve this goal by covering major aspects
of CNS barrier sciences and by making a special effort to include novel research methodology such as
advanced intravital microscopy, mathematical modelling, bioinformatics and bioengineering; which will allow
participants to obtain insights in brain barrier function from novel angles. This interdisciplinary knowledge
exchange will be fostered by invited talks and daily poster presentations.
The meeting will start with a keynote session on the role of the brain barriers in regulating CNS immune
privilege and conclude with a trendsetting keynote session on chip technology for bioengineering the brain
barriers. An additional 7 sessions will address: i) the role of brain barriers in CNS fluid flow, ii) the brain barriers
in development and homeostasis, iii) brain barriers bioinformatics including introduction of a novel data-mining
platform, the BBBHub, iv) molecular mechanisms regulating barrier integrity, v) the role of brain barriers in
tumor growth and brain metastases, vi) novel concepts in drug delivery across the brain barriers, and, vii) brain
barrier microenvironment in health and disease.
The GRC Barriers of the CNS stands out from other brain barriers conferences by bringing together a
multidisciplinary group of senior and junior, academic and non-academic, basic and clinical scientists from
around the world. The conference provides a protected environment for presenting ongoing and unpublished
research promoting new ideas and novel interdisciplinary and translational collaborations.
The preceding 2-day “Barriers” GRS is organized by junior investigators at the postdoctoral level and is
intended to introduce younger scientists (postgraduate students, post-docs, junior faculty) to the field's
methods and issues and to facilitate networking and provide mentorship opportunities.
This application addresses a major public health concern, diseases of the CNS. Improving our knowledge
regarding brain barrier structure and function is prerequisite to overcome these barriers to achieve appropriate
diagnosis and therapy of neurological disorders ranging from brain tumors to Alzheimer's disease, which is
presently limited to symptomatic and palliative measures. Instructing young researchers to think of innovative
and novel solutions and to bridge disciplinary interfaces will advance the capacity to bring new approaches to
realize the untapped potential for the treatment of CNS disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pharmacology Core
-
批准号:10305364
-
项目类别:
-
资助金额:$20.9万
-
财政年份:2021
-
负责人:William Elmquist
-
依托单位:
Pharmacology Core
-
批准号:10704629
-
项目类别:
-
资助金额:$37.28万
-
财政年份:2021
-
负责人:William Elmquist
-
依托单位:
Pharmacology Core
-
批准号:10492771
-
项目类别:
-
资助金额:$23.54万
-
财政年份:2021
-
负责人:William Elmquist
-
依托单位:
Influence of Anti-Angiogenic Therapy on Drug Delivery to Brain Tumors
-
批准号:8554379
-
项目类别:
-
资助金额:$47.66万
-
财政年份:2012
-
负责人:William Elmquist
-
依托单位:
Influence of Anti-Angiogenic Therapy on Drug Delivery to Brain Tumors
-
批准号:8711598
-
项目类别:
-
资助金额:$4.89万
-
财政年份:2012
-
负责人:William Elmquist
-
依托单位:
Influence of Anti-Angiogenic Therapy on Drug Delivery to Brain Tumors
-
批准号:9105773
-
项目类别:
-
资助金额:$49.34万
-
财政年份:2012
-
负责人:William Elmquist
-
依托单位:
Influence of Anti-Angiogenic Therapy on Drug Delivery to Brain Tumors
-
批准号:8900366
-
项目类别:
-
资助金额:$49.36万
-
财政年份:2012
-
负责人:William Elmquist
-
依托单位:
Influence of Anti-Angiogenic Therapy on Drug Delivery to Brain Tumors
-
批准号:8436561
-
项目类别:
-
资助金额:$54.03万
-
财政年份:2012
-
负责人:William Elmquist
-
依托单位:
Influence of Anti-Angiogenic Therapy on Drug Delivery to Brain Tumors
-
批准号:8702251
-
项目类别:
-
资助金额:$48.88万
-
财政年份:2012
-
负责人:William Elmquist
-
依托单位:
Improving Delivery of Molecularly-Targeted Therapy to Invasive Glioma Cells
-
批准号:8434913
-
项目类别:
-
资助金额:$28.86万
-
财政年份:2010
-
负责人:William Elmquist
-
依托单位:
Improving Delivery of Molecularly-Targeted Therapy to Invasive Glioma Cells
-
批准号:8608423
-
项目类别:
-
资助金额:$29.79万
-
财政年份:2010
-
负责人:William Elmquist
-
依托单位:
Improving Delivery of Molecularly-Targeted Therapy to Invasive Glioma Cells
-
批准号:8215833
-
项目类别:
-
资助金额:$30.7万
-
财政年份:2010
-
负责人:William Elmquist
-
依托单位:
Improving Delivery of Molecularly-Targeted Therapy to Invasive Glioma Cells
-
批准号:7885075
-
项目类别:
-
资助金额:$32.9万
-
财政年份:2010
-
负责人:William Elmquist
-
依托单位:
Improving Delivery of Molecularly-Targeted Therapy to Invasive Glioma Cells
-
批准号:8054962
-
项目类别:
-
资助金额:$30.69万
-
财政年份:2010
-
负责人:William Elmquist
-
依托单位:
Improving the CNS Delivery of Anti-retroviral Compounds
-
批准号:6697421
-
项目类别:
-
资助金额:$27.95万
-
财政年份:2002
-
负责人:William Elmquist
-
依托单位:
Improving the CNS Delivery of Anti-retroviral Compounds
-
批准号:7047903
-
项目类别:
-
资助金额:$27.27万
-
财政年份:2002
-
负责人:William Elmquist
-
依托单位:
Improving the CNS Delivery of Anti-retroviral Compounds
-
批准号:6874448
-
项目类别:
-
资助金额:$27.93万
-
财政年份:2002
-
负责人:William Elmquist
-
依托单位:
Improving the CNS Delivery of Anti-retroviral Compounds
-
批准号:7233650
-
项目类别:
-
资助金额:$26.48万
-
财政年份:2002
-
负责人:William Elmquist
-
依托单位:
Improving the CNS Delivery of Anti-retroviral Compounds
-
批准号:6627800
-
项目类别:
-
资助金额:$27.93万
-
财政年份:2002
-
负责人:William Elmquist
-
依托单位:
MRP-MEDIATED DRUG TRANSPORT IN THE BBB
-
批准号:6513123
-
项目类别:
-
资助金额:$5.45万
-
财政年份:1998
-
负责人:William Elmquist
-
依托单位: